A case report described a woman with endometrial cancer in India with an extremely rare blood group type, complicating blood ...

Agios Pharmaceuticals wins FDA approval for Aqvesme in alpha- and beta-thalassemia, making mitapivat the only approved option, despite a new REMS.

NEW ORLEANS, LA—For patients at high cardiac risk who undergo major general or vascular surgery, a liberal approach to transfusion is no better than the more commonly accepted restrictive approach ...

HEMOLYTIC transfusion reactions may occur after the administration of donor bloods even when they have apparently been shown compatible by crossmatch tests. Often ...

ABSTRACT: Hemolytic Disease of the Fetus and Newborn (HDFN) results from fetal-maternal blood group incompatibility, particularly involving the RhD antigen. Despite preventive strategies, HDFN remains ...

Hemolytic disease of the fetus and newborn and transfusion reactions can occur in D variant individuals due to anti-D alloimmunization. Hemolytic disease of the fetus and newborn (HDFN) and ...

Irregular red blood cell (RBC) antibodies are antibodies against blood group antigens other than ABO antigens and can cause difficulties in blood typing and cross-matching, hemolytic transfusion ...

Please provide your email address to receive an email when new articles are posted on . Practice patterns vary widely for management of hemolytic disease of the fetus and newborn (HDFN). Researchers ...

A recently published study of blood donors in Indonesia found that the O-positive blood type was the most common among the national population. A large-scale pioneer study has been conducted in ...

Careful attention should be afforded to exclude the possibility of HDFN during antenatal screening. In the Asian Journal of Transfusion Science, physicians presented the case of infant ABO hemolytic ...